NeuroMetrix (NASDAQ:NURO) and Adagio Medical (NASDAQ:ADGM) Head-To-Head Comparison

Profitability

This table compares NeuroMetrix and Adagio Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeuroMetrix	-203.71%	-42.56%	-39.26%
Adagio Medical	N/A	160.59%	40.99%

Risk and Volatility

NeuroMetrix has a beta of 2.15, suggesting that its share price is 115% more volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.21, suggesting that its share price is 79% less volatile than the S&P 500.

Earnings & Valuation

This table compares NeuroMetrix and Adagio Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroMetrix	$3.77 million	2.38	-$6.53 million	($4.59)	-0.95
Adagio Medical	$266,000.00	61.30	-$2.13 million	N/A	N/A

Adagio Medical has lower revenue, but higher earnings than NeuroMetrix.

Institutional & Insider Ownership

19.4% of NeuroMetrix shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 7.3% of NeuroMetrix shares are held by insiders. Comparatively, 53.5% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Adagio Medical beats NeuroMetrix on 7 of the 9 factors compared between the two stocks.

About NeuroMetrix

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

About Adagio Medical

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.